was read the article
array:25 [ "pii" => "S2173580814001540" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2013.03.007" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "485" "copyright" => "Sociedad Española de Neurología" "copyrightAnyo" => "2013" "documento" => "article" "crossmark" => 0 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2015;30:50-61" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4187 "formatos" => array:3 [ "EPUB" => 85 "HTML" => 3372 "PDF" => 730 ] ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0213485313000674" "issn" => "02134853" "doi" => "10.1016/j.nrl.2013.03.002" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "485" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 0 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2015;30:50-61" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 9883 "formatos" => array:3 [ "EPUB" => 74 "HTML" => 8288 "PDF" => 1521 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Demencia frontotemporal variante conductual: biomarcadores, una aproximación a la enfermedad" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "50" "paginaFinal" => "61" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Biomarkers: A new approach to behavioural variant frontotemporal dementia" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2035 "Ancho" => 2167 "Tamanyo" => 247149 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Correlación clínica, molecular y genética de las degeneraciones lobares frontotemporales.</p> <p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Las flechas indican la relación entre los síndromes clínicos y la patología subyacente, las de trazo continuo señalan las asociaciones más fuertes. Asimismo se indica el subtipo histopatológico más frecuente en cada caso. DFT: demencia frontotemporal; DLFT: degeneración lobar frontotemporal; SPSP: síndrome de parálisis supranuclear progresiva; SCB: síndrome corticobasal; APPNF: afasia primaria progresiva no fluente; DFT vc: demencia frontotemporal variante conductual; DS: demencia semántica; DFT-EMN: demencia frontotemporal asociada a enfermedad de la motoneurona; PSP: parálisis supranuclear progresiva; DCB: degeneración corticobasal; PiD: enfermedad de Pick; MAPT: microtubule associated protein tau; FUS: proteína de fusión en sarcoma; PGRN: progranulina; VCP: valosin containing protein; TARDBP: proteína fijadora de ADN TAR 43; CHMP2B: charged multivesicular body protein 2<span class="elsevierStyleHsp" style=""></span>B. Los subtipos DLFT-TDP 1-3 se han clasificado según el esquema de Mackenzie.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Fernández-Matarrubia, J.A. Matías-Guiu, T. Moreno-Ramos, J. Matías-Guiu" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Fernández-Matarrubia" ] 1 => array:2 [ "nombre" => "J.A." "apellidos" => "Matías-Guiu" ] 2 => array:2 [ "nombre" => "T." "apellidos" => "Moreno-Ramos" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Matías-Guiu" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173580814001540" "doi" => "10.1016/j.nrleng.2013.03.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001540?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485313000674?idApp=UINPBA00004N" "url" => "/02134853/0000003000000001/v2_201705310930/S0213485313000674/v2_201705310930/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2173580814001473" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2013.03.006" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "488" "copyright" => "Sociedad Española de Neurología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "cor" "cita" => "Neurologia. 2015;30:62-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2115 "formatos" => array:3 [ "EPUB" => 48 "HTML" => 1537 "PDF" => 530 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Failure mode and effect analysis applied to the procedure for intrathecal chemotherapy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "62" "paginaFinal" => "64" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Análisis de modos de fallo y sus efectos aplicado al procedimiento de quimioterapia intratecal" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 298 "Ancho" => 2289 "Tamanyo" => 39608 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Diagram of intrathecal chemotherapy process.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. de la Riva, M.T. Martinez Zabaleta, M. Arruti González, M.A. Urtasun Ocariz" "autores" => array:4 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "de la Riva" ] 1 => array:2 [ "nombre" => "M.T." "apellidos" => "Martinez Zabaleta" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Arruti González" ] 3 => array:2 [ "nombre" => "M.A." "apellidos" => "Urtasun Ocariz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213485313000923" "doi" => "10.1016/j.nrl.2013.03.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485313000923?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001473?idApp=UINPBA00004N" "url" => "/21735808/0000003000000001/v2_201706020304/S2173580814001473/v2_201706020304/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2173580814001527" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2011.07.010" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "268" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 0 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2015;30:42-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 9990 "formatos" => array:3 [ "EPUB" => 85 "HTML" => 6677 "PDF" => 3228 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Hallucinogenic drugs in pre-Columbian Mesoamerican cultures" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "42" "paginaFinal" => "49" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Alucinógenos en las culturas precolombinas mesoamericanas" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1285 "Ancho" => 900 "Tamanyo" => 213754 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Fray Bernardino de Sahagún</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Carod-Artal" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Carod-Artal" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213485311002696" "doi" => "10.1016/j.nrl.2011.07.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485311002696?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001527?idApp=UINPBA00004N" "url" => "/21735808/0000003000000001/v2_201706020304/S2173580814001527/v2_201706020304/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Biomarkers: a new approach to behavioural variant frontotemporal dementia" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "50" "paginaFinal" => "61" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Fernández-Matarrubia, J.A. Matías-Guiu, T. Moreno-Ramos, J. Matías-Guiu" "autores" => array:4 [ 0 => array:4 [ "nombre" => "M." "apellidos" => "Fernández-Matarrubia" "email" => array:2 [ 0 => "martafmatarrubia@gmail.com" 1 => "marta_fm1@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "J.A." "apellidos" => "Matías-Guiu" ] 2 => array:2 [ "nombre" => "T." "apellidos" => "Moreno-Ramos" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Matías-Guiu" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Neurología, Hospital Clínico San Carlos, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Demencia frontotemporal variante conductual: biomarcadores, una aproximación a la enfermedad" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2049 "Ancho" => 2165 "Tamanyo" => 232089 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Clinical, molecular, and genetic correlations in frontotemporal lobar degeneration. Arrows indicate the links between clinical syndromes and underlying disease, while continuous lines show the most robust associations. The most frequent histopathological subtype is listed for each syndrome. FTD: frontotemporal dementia; FTLD: frontotemporal lobar degeneration; PSPS: progressive supranuclear palsy syndrome; CBS: corticobasal syndrome; PNFA: progressive nonfluent aphasia; bv-FTD: behavioural variant frontotemporal dementia; SD: semantic dementia; FTD-MND: frontotemporal dementia associated with motor neuron disease; PSP: progressive supranuclear palsy; CBD: corticobasal degeneration; PiD: Pick disease; MAPT: microtubule associated protein tau; FUS: fused-in sarcoma protein; PGRN: progranulin; VCP: valosin containing protein; TARDBP: TAR DNA-binding protein 43; CHMP2B: charged multivesicular body protein 2B. FTLD-TDP subtypes 1-3 are designated according to Mackenzie's classification.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The term frontotemporal lobar degeneration (FTLD) designates a pathological concept that includes a group of molecular diseases that are classified according to the protein that accumulates in the central nervous system. In 2007, Cairns et al.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> established 4 main subtypes according to the protein deposits: tauopathies (FTLD-tau), ubiquitinopathies (FTLD-U), dementia without specific histopathological changes, and neuronal intermediate filament inclusion disease. Since then, following new breakthroughs in pathology and molecular biology, this classification system has been modified. FTLD cases are now classified into 3 main subtypes according to pathology: FTLD associated with tau protein (FTLD-tau), FTLD associated with the TAR DNA-binding protein 43 (FTLD-TDP), and FTLD associated with the fused-in sarcoma protein (FTLD-FUS). Only a very small percentage of cases will not fit any of these subtypes (FTLD-other).<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Each of these main pathological groups can be subdivided into different entities or variants according to the distribution and morphology of protein inclusions and the histological characteristics specific to the case (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). These groups give rise to 6 well-defined syndromes: the 3 clinical variants of frontotemporal dementia or FTD (behavioural variant frontotemporal dementia [bv-FTD], progressive nonfluent aphasia [PNFA], semantic dementia [SD]); frontotemporal dementia associated with motor neuron disease (FTD-MND); progressive supranuclear palsy syndrome (PSPS); and corticobasal syndrome (CBS).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">A small percentage of cases with clinical features suggesting FTD actually have Alzheimer disease (AD).<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This finding is more frequent in cases of logopenic primary progressive aphasia (PPA),<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> but it has also been described in some cases of SD (10%)<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> and bv-FTD (5%-7%).<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5–7</span></a> Cases of AD with an antemortem diagnosis of bv-FTD are referred to as frontal-variant AD.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The purpose of this study is to revise the clinical-pathological and biomolecular correlations in FTD subtypes, especially bv-FTD, as well as the diagnostic accuracy of biomarkers used to hypothesise which disease was responsible for clinical symptoms.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Clinical-pathological and biomolecular correlations in frontotemporal lobar degeneration</span><p id="par0020" class="elsevierStylePara elsevierViewall">FTLDs have classically been regarded as a heterogeneous group of neurodegenerative diseases and researchers have found it extraordinarily difficult to establish links between clinical presentation and the underlying pathological process. Doctors also believed it was not possible to deduce the type of clinical manifestation based on the pathological diagnosis. Advances in neuropathology, biochemistry, molecular biology, and genetics now let us establish clinical, histological, biomolecular, and genetic correlations, in addition to links between clinical and pathological findings.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In 2011, Josephs et al.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> published a review of several clinical-pathological studies<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10–17</span></a> performed in the preceding decade in 6 hospitals in the United States, Canada, the UK, and Australia, including a total of 544 cases of FTLD. They observed that bv-FTD showed similar percentages of underlying FTLD-tau and FTLD-TDP. Almost all cases of PSPS and CBS presented FTLD-tau, whereas 100% of the cases of FTD-MND displayed FTLD-TDP. FTLD-TDP was present in 83% of the patients with SD, whereas PNFA was fundamentally associated with FTLD-tau (70%). Examining by specific groups (FTLD-TDP and FTLD-tau), these researchers found significant associations between clinical phenotype and histopathological subtype, except for PNFA and the FTLD-tau subtype, for which associations were not statistically significant. Patients with bv-FTD and tauopathy were associated with Pick disease (PiD) in 70% of all cases. Those with TDP histopathology demonstrated an association with subtype 1 in the Mackenzie et al. classification.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Nevertheless, the association between bv-FTD and the histopathological subtype was not robust (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">In some cases of bv-FTD, doctors may find clinical features that point towards a specific histopathological subtype.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> One clinical subtype is characterised by changes in behaviour and personality, especially hypersexuality, hyperphagia, and stereotyped or obsessive behaviour. This subtype is strongly associated with atypical FTLD with immunoreactivity to ubiquitin only (aFTLD-U).<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">20,21</span></a> These cases also show very early onset (mean age of about 40 years), and they are typified by pronounced striatal atrophy.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22,23</span></a> On the other hand, the coexistence of psychotic symptoms or signs of motor neuron disease (MND) points to FTLD-TDP type 3 pathology,<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> whereas apathy as the dominant trait is indicative of FTLD-TDP type 1 associated with <span class="elsevierStyleItalic">PGRN</span> mutations.<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">25,26</span></a> The coexistence of marked disinhibition and alteration of the semantic axis of language suggests tau pathology associated with mutation of the microtubule-associated protein tau (MAPT) gene.<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14,26,27</span></a> The presence of vertical supranuclear gaze palsy is associated with tau pathology, and specifically with corticobasal degeneration; to a lesser extent, it is associated with progressive supranuclear palsy (PSP).<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Although the clinical-pathological correlations for the FTLD-FUS subtype have undergone less study,<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">29–36</span></a> it seems there is also an association between clinical phenotype and FTLD-FUS. Neuronal intermediate filament inclusion disease has been linked to 3 syndromes; the most frequent is bv-FTD, followed by FTD-MND and CBS/primary lateral sclerosis. Basophilic inclusion body disease is associated with bv-FTD, FTD-MND, motor neuron diseases, and juvenile amyotrophic lateral sclerosis (JALS). There is a strong association between aFTLD-U and bv-FTD. There are no clinical-pathological studies on FTLD without inclusions, or on FTLD with cytoplasmic inclusions that are immunoreactive to proteins in the ubiquitin-proteasome pathway and negative for TDP-43 (FTLD-UPS).</p><p id="par0040" class="elsevierStylePara elsevierViewall">Although one specific syndrome tends to be dominant in the first 4 years, it is common for different clinical syndromes in FTD to overlap as the disease progresses.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> Kertesz et al.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> prospectively studied 262 patients with clinical criteria of FTD. During follow-up, they documented the appearance of second and sometimes even third clinical syndromes. Patients with bv-FTD developed PNFA in 50% of the cases, CBS/PSPS in 22.5% of the cases, and SD in about 16% of the cases. Slightly more than 50% of the PNFA cases developed bv-FTD and a third developed CBS/PSPS. The rest of the PNFA cases did not exhibit any other syndromes. Three-quarters of the patients with SD developed bv-FTD and the rest did not progress to exhibit other clinical syndromes. Cases with CBS/PSPS were likely to develop bv-FTD (50%) or PNFA (50%).</p><p id="par0045" class="elsevierStylePara elsevierViewall">Since the same patient may manifest different clinical syndromes as the disease progresses, it is possible to state that the same histopathological subtype may elicit different types of clinical disease due to unknown aetiological or neuropathological mechanisms.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Clinical-pathological correlations in the genetic variants of frontotemporal lobar degeneration</span><p id="par0050" class="elsevierStylePara elsevierViewall">Although most FTLD cases are sporadic, a small percentage of them are associated with specific genetic mutations. Seven genes are currently known to be involved in cases of familial FTLD: <span class="elsevierStyleItalic">MAPT</span>, the progranulin gene (<span class="elsevierStyleItalic">PGRN</span>), <span class="elsevierStyleItalic">C9ORF72</span>, valosin containing protein-1 (<span class="elsevierStyleItalic">VCP-1</span>), charged multivesicular body protein 2B (<span class="elsevierStyleItalic">CHMP2B</span>), TAR DNA-binding protein 43 (<span class="elsevierStyleItalic">TARDBP</span>) and fused-in sarcoma (<span class="elsevierStyleItalic">FUS</span>). Mutations in the <span class="elsevierStyleItalic">MAPT</span>, <span class="elsevierStyleItalic">PGRN</span>, and <span class="elsevierStyleItalic">C9ORF72</span> are responsible for most FTD cases with an autosomal dominant inheritance pattern.</p><p id="par0055" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">MAPT</span> mutations<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a> are typically associated with FTLD-tau pathology and do not display a specific histological pattern;<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">40</span></a> histological presentations may include PiD, PSP, and corticobasal degeneration (CBD).<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">41</span></a> Patients with <span class="elsevierStyleItalic">MAPT</span> gene mutations usually present a bv-FTD phenotype, which is occasionally associated with extrapyramidal symptoms.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> This group characteristically presents pronounced symmetrical atrophy of the anterior medial temporal and orbitofrontal regions,<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">42,43</span></a> and it is therefore quite common for the disease to manifest as SD with signs of bv-FTD (or bv-FTD with changes in the semantic processing of language). Disinhibition is a particularly common feature among these patients.<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">23,26,27</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">Familial cases associated with <span class="elsevierStyleItalic">PGRN</span> mutations present a typical neuropathology pattern with marked atrophy at the level of the frontal lobe, caudate nucleus, substantia nigra, and medial area of the thalamus. Unlike <span class="elsevierStyleItalic">MAPT</span> mutations, which are associated with tauopathy, <span class="elsevierStyleItalic">PGRN</span> mutations are associated with deposits of TDP-43, especially in type 1 FTLD-TDP according to Mackenzie's classification.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Neuronal intranuclear inclusions with a ‘cat's eye’ or ‘lentiform’ appearance are the most striking histological finding.<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">44–46</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">Clinically, expression of <span class="elsevierStyleItalic">PGRN</span> mutations varies considerably, even within the same family in addition to between different families. Age at onset is also quite variable, once again, even among members of the same family.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">47</span></a> These mutations may present as CBS,<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48–51</span></a> PNFA,<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">23,51,52</span></a> and bv-FTD,<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> with apathy as the dominant trait.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> Cases of associated MND are exceptional.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">53</span></a> In patients with <span class="elsevierStyleItalic">PGRN</span> mutations, even when asymptomatic, plasma levels of <span class="elsevierStyleItalic">PGRN</span> are very low.<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">47,54–56</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">Hexanucleotide repeat expansion of the nucleotide string GGGGCC in the first intron of the <span class="elsevierStyleItalic">C9ORF72</span> gene is not only the known mutation most frequently associated with ALS and FTD-MND, but also the second-most frequent in FTLD after <span class="elsevierStyleItalic">PGRN</span> mutations. According to DeJesus-Hernandez et al.,<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">57</span></a> 12% of the familial cases of FTD and 22.5% of ALS cases are associated with that mutation. Slightly higher prevalences have been found in Nordic populations: the mutation was present in 46% of the population with familial ALS, 21.1% in sporadic ALS, and 29.3% in FTD in Finland.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">58</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Mutations in the <span class="elsevierStyleItalic">C9ORF72</span> gene, associated with FTLD-TDP pathology, may manifest clinically as bv-FTD, ALS, or FTD-MND. Presentations vary considerably, even between members of the same family. In the study by DeJesus-Hernandez et al.,<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">57</span></a> 26.9% of the patients with FTLD also presented ALS, and more than 30% had family members with ALS.</p><p id="par0080" class="elsevierStylePara elsevierViewall">Mutations in the <span class="elsevierStyleItalic">VCP-1</span> gene are associated with a rare autosomal dominant disorder that presents with myopathy (90%), Paget's disease of bone, and less frequently, FTD (30%). FTD usually appears years after the onset of muscular symptoms.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">59</span></a> According to Sampathu's and Mackenzie's histopathological classification systems for types of FTLD-TDP, the above entity is known as subtype 4.<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">60</span></a> Biopsy typically reveals myopathic inclusion bodies.</p><p id="par0085" class="elsevierStylePara elsevierViewall">Mutations in the <span class="elsevierStyleItalic">CHMP2B</span> gene, which until now have only been detected in 5 families, are typically associated with bv-FTD, with or without associated pyramidal or extrapyramidal signs.<a class="elsevierStyleCrossRefs" href="#bib0305"><span class="elsevierStyleSup">61,62</span></a> Myoclonia may also appear in later stages.<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">61</span></a> There are only 2 published cases of associated MND.<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">63</span></a> From a neuropathology viewpoint, they are associated with FTLD-UPS.</p><p id="par0090" class="elsevierStylePara elsevierViewall">Mutations in the <span class="elsevierStyleItalic">TARDBP</span> and <span class="elsevierStyleItalic">FUS</span> genes are fundamentally associated with cases of familial ALS and only rarely do they cause FTD.<a class="elsevierStyleCrossRefs" href="#bib0320"><span class="elsevierStyleSup">64–67</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">The relationship between different clinical phenotypes and underlying disease in genetic cases differs from that found in sporadic cases. For example, PNFA and CBS in sporadic cases are more commonly associated with FTLD-tau, whereas in familial cases, the same symptoms would be more frequently found in FTLD-TDP (especially type 1). Either sporadic or familial bv-FTD may be associated with FTLD-tau or FTLD-TDP indiscriminately. Cases of SD and PSPS are almost always sporadic.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Neuroimaging biomarkers</span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Structural neuroimaging: brain magnetic resonance</span><p id="par0100" class="elsevierStylePara elsevierViewall">Neurodegenerative diseases are associated with progressive cerebral atrophy. This process can be measured and quantified using structural neuroimaging techniques, including brain MRI. Measuring atrophy using neuroimaging techniques has been shown to be a useful biomarker in other neurodegenerative diseases.<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">68,69</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">The relationship between different FTD syndromes and the pattern of atrophy is now well-defined. In general, bv-FTD is associated with atrophy predominantly affecting the frontal lobe, insula, anterior cingulate, and anterior temporal lobe in an asymmetrical pattern (predominantly in the non-dominant hemisphere). SD is associated with asymmetrical atrophy affecting the anterior inferior temporal lobes, whereas PNFA is associated with asymmetrical atrophy of the anterior perisylvian cortex (more pronounced in the dominant hemisphere).<a class="elsevierStyleCrossRefs" href="#bib0350"><span class="elsevierStyleSup">70–72</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">Lindberg et al.<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">73</span></a> analysed the volumes of 9 cortical regions of interest in 61 individuals (27 controls, 12 with bv-FTD, 9 with PNFA, and 13 with SD) and compared findings between the different clinical entities. They observed that it was possible to distinguish between these syndromes with relatively high levels of sensitivity and specificity. Identifying atrophy as temporal or frontal was the best discriminator between SD and the other 2 clinical subtypes. Laterality of atrophy (right vs left) was the most useful feature for discriminating between bv-FTD and PNFA. Despite the above, doctors must be mindful that there is a certain degree of heterogeneity and overlap between neuroanatomical findings, and that brain MRI may not show alterations in early stages of disease.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Cerebral alterations found in bv-FTD are not limited to the cerebral cortex. Atrophy also affects numerous subcortical regions, including the amygdala, hippocampus, caudate nucleus, striatum, putamen, thalamus, and hypothalamus.<a class="elsevierStyleCrossRefs" href="#bib0370"><span class="elsevierStyleSup">74,75</span></a> In fact, amygdalar atrophy may be a useful marker for distinguishing between bv-FTD and Alzheimer disease.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">74</span></a> Similarly, Chao et al.<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">76</span></a> observed that reduced volume of frontal white matter is indicative of reduction in volume in adjacent grey matter in patients with bv-FTD, and that different FTD subtypes are associated with different white matter atrophy patterns.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Early changes, progression, and stages of behavioural variant frontotemporal dementia</span><p id="par0120" class="elsevierStylePara elsevierViewall">Developing automated quantitative methods, such as voxel-based morphometry and cortical thickness mapping, has been crucial for the detection of selective atrophy of the anterior cingulate and the frontal and insular cortices in early stages of bv-FTD.<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">71,77,78</span></a> This differs from the atrophy pattern observed in other FTD variants and other types of dementia, including AD.<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">79</span></a> Macroscopic changes may not be apparent in early clinical phases, even though molecular disease is known to be present in the brain several years before symptoms appear (preclinical phase). The yearly rate of overall cerebral atrophy in bv-FTD is as high as 8%, or nearly twice that observed in AD. However, some patients with bv-FTD may present lower rates (0.3% yearly) that resemble those seen in healthy individuals.<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">80</span></a> This low figure may be due to phenocopies being included among cases.</p><p id="par0125" class="elsevierStylePara elsevierViewall">The advance of brain atrophy in FTD has been studied by analysing the pattern of atrophy in patients with different progression times.<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">81</span></a> In initial phases, atrophy generally affects the medial and orbital frontal lobe. It subsequently affects the temporal pole, hippocampal formation, frontal dorsolateral cortex, and basal ganglia. This progression pattern has been linked to the volume of the cortical and subcortical regions, and to underlying neuronal loss.<a class="elsevierStyleCrossRefs" href="#bib0410"><span class="elsevierStyleSup">82,83</span></a> As a result, determining the atrophy pattern is a useful way of identifying the stage of the disease.<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">84,85</span></a> Based on these findings, Kipps et al.<a class="elsevierStyleCrossRef" href="#bib0430"><span class="elsevierStyleSup">86</span></a> proposed a visual assessment scale using brain MRI.</p><p id="par0130" class="elsevierStylePara elsevierViewall">Seeley et al.<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">77</span></a> carried out a case-control study in patients with bv-FTD at different stages of progression. These researchers classified cases in 3 groups according to scores on the Clinical Dementia Rating scale: CDR 0.5, CDR 1, and CDR 2-3. The group in the mildest stage (CDR 0.5) displayed bilateral but asymmetrical atrophy, predominantly in the right hemisphere, affecting different regions of the frontal lobe (rostromedial, frontal pole, dorsolateral, and orbitofrontal), anterior cingulate cortex, anterior insula, hippocampus, and subcortical areas (ventral striatum, dorsomedial thalamus). Atrophy was more widespread in the above areas in subjects with higher CDR scores, especially in the frontal lobe, and it extended to more posterior areas including the posterior insula and the temporal and parietal lobes. Another study of cases of bv-FTD confirmed by a pathology study showed similar results.<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">87</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">Subsequent studies suggest that the areas affected in early stages of the disease (frontal, insular, and anterior cingulate) form part of a structurally and functionally differentiated circuit called the salience network (SN). The anatomical substrate of this neural circuit are the von Economo cells, a unique neuronal population that probably plays a fundamental role in social cognition.<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">88,89</span></a> A study using functional cerebral MRI found the clinical severity of bv-FTD to be correlated with the degree of disruption in right-sided SN connectivity.<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">90</span></a> Nevertheless, given the heterogeneity of bv-FTD pathology, it is not clear whether or not this neural circuit undergoes similar changes in all histopathological subtypes.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Correlation between anatomy and pathological subtype</span><p id="par0140" class="elsevierStylePara elsevierViewall">An even more interesting prospect is neuroimaging, which has great potential for exploring the pathological process underlying the syndrome.</p><p id="par0145" class="elsevierStylePara elsevierViewall">The first studies carried out provided contradictory results; some showed differences between patients with FTLD-tau and FTLD-U,<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">91</span></a> while others found very similar patterns of atrophy.<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">92</span></a> In 2009, Whitwell et al.<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">93</span></a> used morphometry to analyse regional cortical atrophy in a cohort of 66 patients with a clinical diagnosis of bv-FTD. They observed that half of the patients presented predominantly frontal atrophy, while the other half showed temporal predominance. Based on these findings, they established 4 anatomical subtypes: frontal-dominant, frontotemporal, temporofrontoparietal, and temporal-dominant. The patients with frontal-dominant and frontotemporal atrophy patterns predominantly presented frontal lobe impairment (orbitofrontal, medial frontal, and dorsolateral regions); atrophy was quite restricted in the first pattern, but less restricted and also appearing in temporal areas in the second. Patients with the temporofrontoparietal pattern characteristically showed temporoparietal and medial frontal atrophy. The least frequent subtype was temporal-dominant, in which atrophy was restricted to the inferior and medial region of the temporal lobe. This pattern was associated with predominantly right-sided atrophy in all cases, and with <span class="elsevierStyleItalic">MAPT</span> mutations in 83% of the cases. <span class="elsevierStyleItalic">PGRN</span> mutations, unlike those previously listed, were never associated with the temporal-dominant subtype; this indicates that the anatomical pattern may be useful in distinguishing between <span class="elsevierStyleItalic">MAPT</span> and <span class="elsevierStyleItalic">PGRN</span> mutations. Cases of the temporal-dominant subtype showed poorer results on language and memory tests, and those with the frontal-dominant subtype scored lower for executive function, but differences were not statistically significant. The most frequent behavioural symptom in subtypes with frontal atrophy was apathy (76%), and this is not the case in the temporal-dominant subtype. Among patients who had undergone pathology studies, there were no clear correlations between the anatomical pattern and pathological subtype except in patients diagnosed with FTLD-TDP associated with MND, whose atrophy patterns were restricted to the frontal lobe. In addition to being associated with TDP-43, the temporofrontoparietal pattern was associated with AD or CBD in 3 subjects. According to these authors, the frontotemporal subtype may be a stage in bv-FTD progression; it would begin as frontal-dominant atrophy and subsequently extend to the temporal lobes. The temporofrontoparietal pattern cannot be explained in the same way. Frontal atrophy detected in this pattern was less pronounced than in cases with a frontal-dominant pattern, and temporal atrophy was also less pronounced than in temporal-dominant cases.<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">93</span></a></p><p id="par0150" class="elsevierStylePara elsevierViewall">In 2011, Rohrer et al.<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">94</span></a> presented a retrospective study in which they analysed clinical, neuropsychological, and neuroimaging data (using voxel-based volumetry and morphometry) in a cohort of 95 patients with a diagnosis of FTLD confirmed by pathology study. These researchers attempted to find clinical-anatomical correlations for all histopathological subtypes. They classified anatomical findings in 4 patterns based on symmetry or asymmetry and the temporal or extratemporal location of atrophy. They observed that specific pathological subtypes exhibited a significant association with distinct clinical syndromes, also finding an association between some subtypes and certain atrophy patterns (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Role of neuroimaging in the differential diagnosis of FTD and other dementia types</span><p id="par0155" class="elsevierStylePara elsevierViewall">It is usually easy to distinguish between FTD and AD based on clinical observation. However, some patients with FTD initially exhibit marked changes in episodic memory, and patients with Alzheimer disease may also show atypical disease presentations. Examples include language-variant AD (usually logopenic PPA), frontal-variant AD (with striking behavioural and executive changes), posterior cortical atrophy (usually presenting with visuospatial and/or visuoperceptual changes and sometimes known as ‘visual variant’), or CBS associated with AD.</p><p id="par0160" class="elsevierStylePara elsevierViewall">Structural MRI with voxel-based morphometry is a useful tool for distinguishing between FTD and AD. FTD exhibits atrophy in the frontal, insular, anterior cingulate, and striate regions, whereas AD shows posterior parietal and occipital atrophy.<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">95</span></a> Regional cortical thickness analysis is also helpful, since AD cases will show cortical thinning at the parietal and precuneal levels.<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">96</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall">Other MRI techniques used in distinguishing AD from FTLD include diffusion tensor imaging sequence<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">97</span></a> (decreased fractional anisotropy in frontal regions in FTLD), arterial spin labelling<a class="elsevierStyleCrossRefs" href="#bib0490"><span class="elsevierStyleSup">98,99</span></a> (hypoperfusion in parietal regions and posterior cingulate in AD vs frontal lobe hypoperfusion in FTLD), and combined techniques using positron-emission tomography (PET) with F18-fluorodeoxyglucose (FDG)/RM.<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">100</span></a></p><p id="par0170" class="elsevierStylePara elsevierViewall">Several studies performed on atypical variants of AD have shown that, regardless of clinical presentation, AD is associated with impairment in the posterior cingulate gyrus, precuneus, posterior parietal regions, and medial temporal regions.<a class="elsevierStyleCrossRefs" href="#bib0505"><span class="elsevierStyleSup">101,102</span></a> Other studies have compared patients with PPA and AD to those with PPA only. They found that the patients with AD (usually associated with logopenic PPA) presented more pronounced temporoparietal atrophy, while those with FTLD had imaging studies showing typical ‘knife-edge’ atrophy of the temporal lobe.<a class="elsevierStyleCrossRefs" href="#bib0515"><span class="elsevierStyleSup">103,104</span></a></p><p id="par0175" class="elsevierStylePara elsevierViewall">Less frequently, FTLD may be confused with Lewy body dementia (LBD), fundamentally in patients who experience visual illusions or hallucinations.<a class="elsevierStyleCrossRefs" href="#bib0525"><span class="elsevierStyleSup">105,106</span></a> A recent study in a small sample suggested that I<span class="elsevierStyleSup">123</span>-MIBG scintigraphy may be useful for distinguishing between these 2 entities, because LBD, unlike FTLD, shows a pronounced decrease in contrast uptake.<a class="elsevierStyleCrossRef" href="#bib0530"><span class="elsevierStyleSup">106</span></a> In another small study, MR images were not useful for differential diagnosis.<a class="elsevierStyleCrossRef" href="#bib0535"><span class="elsevierStyleSup">107</span></a></p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Functional neuroimaging: cerebral positron-emission tomography and single-photon emission computed tomography</span><p id="par0180" class="elsevierStylePara elsevierViewall">Recent years have seen increasing use of functional neuroimaging techniques, including single-photon emission computed tomography (SPECT) using Tc<span class="elsevierStyleSup">99m</span>-hexamethylpropyleneamine oxime, or <span class="elsevierStyleSup">18</span>F-FDG-PET, in the diagnosis of bv-FTD. Hypoperfusion/hypometabolism is observed in frontal regions in bv-FTD, whereas AD displays hypoperfusion in the temporoparietal and posterior cingulate areas.<a class="elsevierStyleCrossRefs" href="#bib0540"><span class="elsevierStyleSup">108,109</span></a> Both SPECT and FDG-PET are more sensitive than brain MRI for detecting the early changes occurring in bv-FTD.<a class="elsevierStyleCrossRef" href="#bib0550"><span class="elsevierStyleSup">110</span></a> FDG-PET is also very important for detecting phenocopies, since these cases will show preserved metabolism in the frontal regions. However, using FDG-PET in patients whose MRI shows clear cerebral atrophy is unlikely to provide any additional benefit.</p><p id="par0185" class="elsevierStylePara elsevierViewall">Some PET techniques employ new radioisotopes. One uses a compound called carbon 11-labelled Pittsburgh compound B, which binds to β-amyloid and has shown promising results for differential diagnosis of AD and FDT,<a class="elsevierStyleCrossRefs" href="#bib0555"><span class="elsevierStyleSup">111,112</span></a> especially in cases displaying language alteration.<a class="elsevierStyleCrossRefs" href="#bib0565"><span class="elsevierStyleSup">113,114</span></a> Other techniques are currently being developed, including PET imaging of tau, PGRN, or FUS. These promising diagnostic tools may be ready for use in the near future.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Biomarkers in plasma and cerebrospinal fluid</span><p id="par0190" class="elsevierStylePara elsevierViewall">Low CSF levels of the 42 amino acid beta-amyloid peptide (A β42), and high levels of tau protein, are biomarkers that are both sensitive and specific for diagnosis of AD.<a class="elsevierStyleCrossRefs" href="#bib0575"><span class="elsevierStyleSup">115,116</span></a> Tau/beta amyloid ratio: A β42 is a useful parameter for distinguishing FTLD from AD since it is lower in FTLD.<a class="elsevierStyleCrossRef" href="#bib0585"><span class="elsevierStyleSup">117</span></a> Researchers have reported high levels of TDP-43 in cerebrospinal fluid from patients whose diagnosis of FTD-MND had not been confirmed by a histopathological study.<a class="elsevierStyleCrossRef" href="#bib0590"><span class="elsevierStyleSup">118</span></a></p><p id="par0195" class="elsevierStylePara elsevierViewall">Various studies have shown that patients with mutations in the <span class="elsevierStyleItalic">PGRN</span> gene display very low plasma levels of PGRN.<a class="elsevierStyleCrossRefs" href="#bib0270"><span class="elsevierStyleSup">54,55,119</span></a> Measuring plasma PGRN levels has been proposed as a sensitive and specific screening method for use in these patients.<a class="elsevierStyleCrossRef" href="#bib0600"><span class="elsevierStyleSup">120</span></a></p><p id="par0200" class="elsevierStylePara elsevierViewall">Other research indicates that plasma levels of TDP-43 may be related to cerebral impairment in patients with FTLD.<a class="elsevierStyleCrossRef" href="#bib0605"><span class="elsevierStyleSup">121</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Conclusions</span><p id="par0205" class="elsevierStylePara elsevierViewall">Picturing FTLD on the molecular level is a way of gaining a more precise understanding of the disease in terms of its causal mechanisms. This also opens the doors to new treatment options. Ligand-specific drugs are currently being developed to search out defined molecular targets.</p><p id="par0210" class="elsevierStylePara elsevierViewall">Of all of the clinical variants, bv-FTD is the most heterogeneous variety, which makes it difficult to predict the underlying disease type. It is possible that this syndrome describes a concept that is too broad and actually includes a number of very different entities. As a result, identifying differential clinical features and defining clinical subtypes may provide better clinical-pathological correlations. In any case, as a complement to clinical evaluation techniques, doctors must develop tools that will deliver in vivo histopathological and molecular diagnoses of these processes.</p><p id="par0215" class="elsevierStylePara elsevierViewall">Structural and functional neuroimaging, biomarkers in laboratory analyses, and genetic studies are being transformed into useful tools for diagnosis or differential diagnosis and for predicting the underlying pathological process. Of all of the biomarkers that have been listed, we should stress the importance of functional neuroimaging. It is more sensitive than structural neuroimaging in early stages of the disease, and it can be used in novel techniques with specific radiotracers (<span class="elsevierStyleSup">11</span>C-labelled Pittsburgh compound B and tracers for tau, PGRN, and FUS). This technique is emerging as an instrument that promises good results in the near future.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflicts of interest</span><p id="par0220" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:13 [ 0 => array:3 [ "identificador" => "xres848379" "titulo" => "Abstract" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Development" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec843494" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres848380" "titulo" => "Resumen" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Desarrollo" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec843495" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Clinical-pathological and biomolecular correlations in frontotemporal lobar degeneration" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Clinical-pathological correlations in the genetic variants of frontotemporal lobar degeneration" ] 7 => array:3 [ "identificador" => "sec0020" "titulo" => "Neuroimaging biomarkers" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0025" "titulo" => "Structural neuroimaging: brain magnetic resonance" ] 1 => array:2 [ "identificador" => "sec0030" "titulo" => "Early changes, progression, and stages of behavioural variant frontotemporal dementia" ] 2 => array:2 [ "identificador" => "sec0035" "titulo" => "Correlation between anatomy and pathological subtype" ] 3 => array:2 [ "identificador" => "sec0040" "titulo" => "Role of neuroimaging in the differential diagnosis of FTD and other dementia types" ] ] ] 8 => array:2 [ "identificador" => "sec0045" "titulo" => "Functional neuroimaging: cerebral positron-emission tomography and single-photon emission computed tomography" ] 9 => array:2 [ "identificador" => "sec0050" "titulo" => "Biomarkers in plasma and cerebrospinal fluid" ] 10 => array:2 [ "identificador" => "sec0055" "titulo" => "Conclusions" ] 11 => array:2 [ "identificador" => "sec0060" "titulo" => "Conflicts of interest" ] 12 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2013-02-27" "fechaAceptado" => "2013-03-16" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec843494" "palabras" => array:6 [ 0 => "Behavioural variant frontotemporal dementia" 1 => "Frontotemporal lobar degeneration" 2 => "Biomarker" 3 => "TDP-43" 4 => "Tau" 5 => "Genetics" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec843495" "palabras" => array:6 [ 0 => "Demencia frontotemporal variante conductual" 1 => "Degeneración lobar frontotemporal" 2 => "Biomarcador" 3 => "TDP-43" 4 => "Tau" 5 => "Genética" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Lobar frontotemporal degeneration (FTLD) encompasses a group of molecular disease defined by the deposition of an abnormal protein in the central nervous system. Behavioural variant frontotemporal dementia (bvFTD) is the most frequent clinical presentation of FTLD. The past two decades of research have contributed to a better understanding of this entity, which may be the first manifestation in many different neurodegenerative disorders.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Development</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We reviewed correlations between clinical, pathological, and genetic findings and the main disease biomarkers of FTLD, with particular interest in bvFTD. Anatomical pathology findings in FTLD are heterogeneous and the syndrome is not associated with any one specific histopathological type. Promising available biomarkers include structural and functional neuroimaging techniques and biochemical and genetic biomarkers. Disease-modifying drugs designed for specific molecular targets that are implicated in FTLD pathogenesis are being developed.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Conclusions</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">BvFTD is a frequent cause of dementia. Of all the clinical variants of FTLD, behavioural variant is the one in which establishing a correlation between clinical and pathological signs is the most problematic. A biomarker evaluation may help predict the underlying pathology; this approach, in conjunction with the development of disease-modifying drugs, offers new therapeutic possibilities.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Development" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Introducción</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Las degeneraciones lobares frontotemporales (DLFT) son un grupo de patologías moleculares que se definen en función de la proteína acumulada en el sistema nervioso central. La demencia frontotemporal variante conductual (DFT vc) es el síndrome clínico de presentación más frecuente. Los avances realizados en los últimos años han contribuido a un mayor conocimiento de esta entidad, que puede ser el modo de presentación de diferentes enfermedades neurodegenerativas.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Desarrollo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Se revisa la correlación entre clínica, patología y genética de las DLFT, en especial de la DFT vc, así como los principales biomarcadores de la enfermedad. La anatomía patológica de la DFT vc es muy variada, sin mostrar asociación significativa con ningún subtipo histopatológico concreto. Entre los biomarcadores disponibles, destacan la neuroimagen anatómica y funcional, los biomarcadores analíticos y la genética. Se están diseñando fármacos dirigidos contra dianas moleculares concretas implicadas en la patogenia de las DLFT.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conclusiones</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">La DFT vc es una causa frecuente de demencia. De entre todas las variantes clínicas de las DLFT, es en la que resulta más difícil establecer una relación clínico-patológica. El uso de biomarcadores puede ayudar a predecir la anatomía patológica subyacente, lo que junto al desarrollo de fármacos ligando-específicos ofrece nuevas posibilidades terapéuticas.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Desarrollo" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Fernández-Matarrubia M, Matías-Guiu JA, Moreno-Ramos T, Matías-Guiu J. Demencia frontotemporal variante conductual: biomarcadores, una aproximación a la enfermedad. Neurología. 2015;30:50–61.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2049 "Ancho" => 2165 "Tamanyo" => 232089 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Clinical, molecular, and genetic correlations in frontotemporal lobar degeneration. Arrows indicate the links between clinical syndromes and underlying disease, while continuous lines show the most robust associations. The most frequent histopathological subtype is listed for each syndrome. FTD: frontotemporal dementia; FTLD: frontotemporal lobar degeneration; PSPS: progressive supranuclear palsy syndrome; CBS: corticobasal syndrome; PNFA: progressive nonfluent aphasia; bv-FTD: behavioural variant frontotemporal dementia; SD: semantic dementia; FTD-MND: frontotemporal dementia associated with motor neuron disease; PSP: progressive supranuclear palsy; CBD: corticobasal degeneration; PiD: Pick disease; MAPT: microtubule associated protein tau; FUS: fused-in sarcoma protein; PGRN: progranulin; VCP: valosin containing protein; TARDBP: TAR DNA-binding protein 43; CHMP2B: charged multivesicular body protein 2B. FTLD-TDP subtypes 1-3 are designated according to Mackenzie's classification.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">FTLD-TDP subtypes 1-4 are designated according to Mackenzie's classification.</p><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">AD: Alzheimer disease; FTLD-FUS: frontotemporal lobar degeneration associated with fused-in sarcoma protein; FTLD-tau: frontotemporal lobar degeneration with tau inclusions; FTLD-TDP: frontotemporal lobar degeneration associated with TAR DNA-binding protein 43; aFTLD-U: atypical frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions; NCI: neuronal cytoplasmic inclusions; NII: neuronal intranuclear inclusions; Ubi: ubiquitin.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Histopathological type and subtype \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Protein \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Histopathology characteristics \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleBold">FTLD-tau</span></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Pick disease</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 3R \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rounded argyrophilic cytoplasmic masses (Pick bodies)<br>Non-pyramidal cells in dentate gyrus and CA1 area of the hippocampus<br>Pyramidal neurons of the frontal and temporal lobes (layers II and VI) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Corticobasal degeneration</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 4R \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rounded tangles in neurons and glia, predominantly in the cortex<br>Ring-shaped tau deposits in astrocytes (glial plaque)<br>Deposits in oligodendrocytes (coiled bodies) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Progressive supranuclear palsy</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 4R \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rounded tangles in neurons and glia, predominantly in the cortex<br>Tufted astrocytes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Dementia with argyrophilic grains</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 4R \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Deposits in dendritic spines<br>Deposits in oligodendrocytes (coiled bodies) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Multisystemic tauopathy</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 4R \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Neocortex (frontal, temporal and parietal lobes)<br>Basal ganglia and brainstem \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Tangle-predominant dementia</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 3R/4R \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cortical neurofibrillary tangles<br>Absence of amyloid plaques \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">FTLD associated with MAPT gene mutation</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 3R, 4R or 3R/4R \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pronounced heterogeneity \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleBold">FTLD-U</span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">FTLD-TDP</span></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Type 1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">TDP-43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Abundant NCIs and dystrophic neurites (DN)<br>Variable NII (cat's eyes) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Type 2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">TDP-43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Abundant DNs<br>Few or no NCIs or NIIs \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Type 3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">TDP-43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Numerous NCIs<br>Few NIIs/DNs \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Type 4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">TDP-43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Numerous NCIs<br>Few NCIs and DNs \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">FTLD-FUS</span></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Neuronal intermediate filament inclusion disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FUS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NCIs positive for FUS, intermediate filaments, and ubiquitin<br>Visible in H&E stain \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Basophilic inclusion body disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FUS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NCIs positive for FUS and ubiquitin and negative for TDP-43, tau, and intermediate filaments<br>Basophils in H&E stain \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Atypical FTLD with ubiquitin-positive inclusions \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FUS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NCIs positive for FUS and ubiquitin and negative for TDP-43, tau, and intermediate filaments \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleBold">FTLD-other</span></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">FTLD without inclusions</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Frontotemporal gliosis and neuronal loss<br>No evidence of inclusions \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">FTLD immunoreactive to proteins in the ubiquitin-proteasome pathway</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ubi \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Inclusions positive for ubiquitin or p62<br>Negative for tau, α-synuclein, α-internexin, TDP-43, and FUS \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"><span class="elsevierStyleBold">No FTLD</span></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">AD</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">tau 3R and 4R<br>β-amyloid \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Neuritic plaques positive for β-amyloid<br>Neurofibrillary tangles positive for tau 3R and 4R \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1431794.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Histopathological and biomolecular classification of types of frontotemporal lobar degeneration</p>" ] ] 2 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">FTLD-TDP subtypes 1-3 are designated according to Mackenzie's classification.</p><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">CBD: corticobasal degeneration; FTD-MND: frontotemporal dementia associated with motor neuron disease; bv-FTD: behavioural variant of frontotemporal dementia; FTLD-FUS: frontotemporal lobar degeneration associated with fused-in sarcoma protein; FTLD-TDP: frontotemporal lobar degeneration associated with TAR DNA-binding protein 43; FTLD-Tau: frontotemporal lobar degeneration with tau inclusions; SD: semantic dementia; FUS: fused-in sarcoma protein; MAPT: microtubule associated protein; PGRN: progranulin; PiD: Pick disease; PSP: progressive supranuclear palsy; CBS: corticobasal syndrome; PSPS: progressive supranuclear palsy syndrome.</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Based on data from Rohrer et al.<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">94</span></a></p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Histopathological type \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Histopathological subtype \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Atrophy pattern \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical syndrome \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " rowspan="4" align="left" valign="top">FTLD-TDP</td><td class="td" title="table-entry " align="left" valign="top">Type 1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Diffuse asymmetrical extratemporal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Variable (bv-FTD) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Type 1 due to <span class="elsevierStyleItalic">PGRN</span> mutation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Diffuse asymmetrical extratemporal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Variable \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Type 3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FTD-MND \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Type 2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Asymmetrical temporal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">SD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " rowspan="4" align="left" valign="top">FTLD-tau</td><td class="td" title="table-entry " align="left" valign="top">Associated with <span class="elsevierStyleItalic">MAPT</span> gene mutation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Symmetrical temporal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">bv-FTD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">PiD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Diffuse asymmetrical extratemporal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Variable \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">CBD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Diffuse asymmetrical extratemporal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Variable \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">PSP \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PSPS \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">FTLD-FUS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Diffuse localised symmetrical \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Early onset bv-FTD \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1431795.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Correlations between histopathology, atrophy pattern, and clinical syndrome</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:121 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-007-0237-2" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2007" "volumen" => "114" "paginaInicial" => "5" "paginaFinal" => "22" "link" => array:1 [ …1] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-009-0612-2" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2010" "volumen" => "119" "paginaInicial" => "1" "paginaFinal" => "4" "link" => array:1 [ …1] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Afasia progresiva primaria: del síndrome a la enfermedad" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nrl.2012.04.003" "Revista" => array:3 [ "tituloSerie" => "Neurologia" "fecha" => "2012" "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.21388" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "2008" "volumen" => "63" "paginaInicial" => "709" "paginaFinal" => "719" "link" => array:1 [ …1] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Focal cortical presentations of Alzheimer's disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awm213" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2007" "volumen" => "130" "paginaInicial" => "2636" "paginaFinal" => "2645" "link" => array:1 [ …1] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The evolution and pathology of frontotemporal dementia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awh598" "Revista" => array:7 [ "tituloSerie" => "Brain" "fecha" => "2005" "volumen" => "128" "paginaInicial" => "1996" "paginaFinal" => "2005" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antemortem diagnosis of frontotemporal lobar degeneration" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.20425" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "2005" "volumen" => "57" "paginaInicial" => "480" "paginaFinal" => "488" "link" => array:1 [ …1] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and pathological evidence for a frontal variant of Alzheimer disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "1999" "volumen" => "56" "paginaInicial" => "1233" "paginaFinal" => "1239" "link" => array:1 [ …1] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuropathological background of phenotypical variability in frontotemporal dementia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-011-0839-6" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2011" "volumen" => "122" "paginaInicial" => "137" "paginaFinal" => "153" "link" => array:1 [ …1] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein. TDP-43" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-006-0189-y" "Revista" => array:7 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2007" "volumen" => "113" "paginaInicial" => "521" "paginaFinal" => "533" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneur.64.10.1449" "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "2007" "volumen" => "64" "paginaInicial" => "1449" "paginaFinal" => "1454" "link" => array:1 [ …1] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinicopathological correlates in frontotemporal dementia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.20203" "Revista" => array:7 [ "tituloSerie" => "Ann Neurol" "fecha" => "2004" "volumen" => "56" "paginaInicial" => "399" "paginaFinal" => "406" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal lobar degeneration: clinical and pathological relationships" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-007-0236-3" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2007" "volumen" => "114" "paginaInicial" => "31" "paginaFinal" => "38" "link" => array:1 [ …1] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-009-0547-7" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2009" "volumen" => "118" "paginaInicial" => "349" "paginaFinal" => "358" "link" => array:1 [ …1] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000191307.69661.c3" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2006" "volumen" => "66" "paginaInicial" => "41" "paginaFinal" => "48" "link" => array:1 [ …1] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal dementia: clinicopathological correlations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.20873" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "2006" "volumen" => "59" "paginaInicial" => "952" "paginaFinal" => "962" "link" => array:1 [ …1] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awl271" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2006" "volumen" => "129" "paginaInicial" => "3081" "paginaFinal" => "3090" "link" => array:1 [ …1] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-006-0138-9" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2006" "volumen" => "112" "paginaInicial" => "539" "paginaFinal" => "549" "link" => array:1 [ …1] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nrl.2013.03.001" "Revista" => array:2 [ "tituloSerie" => "Neurología" "fecha" => "2013" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-011-0816-0" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2011" "volumen" => "122" "paginaInicial" => "99" "paginaFinal" => "110" "link" => array:1 [ …1] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "FUS pathology defines the majority of tau and TDP-43-negative frontotemporal lobar degeneration" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-010-0698-6" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2010" "volumen" => "120" "paginaInicial" => "33" "paginaFinal" => "34" "link" => array:1 [ …1] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anatomic correlates of stereotypies in frontotemporal lobar degeneration" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neurobiolaging.2007.04.027" "Revista" => array:6 [ "tituloSerie" => "Neurobiol Aging" "fecha" => "2008" "volumen" => "29" "paginaInicial" => "1859" "paginaFinal" => "1863" "link" => array:1 [ …1] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Caudate atrophy on MRI is a characteristic feature of FTLD-FUS" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-1331.2010.02975.x" "Revista" => array:6 [ "tituloSerie" => "Eur J Neurol" "fecha" => "2010" "volumen" => "17" "paginaInicial" => "969" "paginaFinal" => "975" "link" => array:1 [ …1] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneurol.2010.146" "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "2010" "volumen" => "67" "paginaInicial" => "826" "paginaFinal" => "830" "link" => array:1 [ …1] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awm331" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2008" "volumen" => "131" "paginaInicial" => "721" "paginaFinal" => "731" "link" => array:1 [ …1] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Two distinct subtypes of right temporal variant frontotemporal dementia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0b013e3181bf9945" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2009" "volumen" => "73" "paginaInicial" => "1443" "paginaFinal" => "1450" "link" => array:1 [ …1] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2002" "volumen" => "125" "paginaInicial" => "732" "paginaFinal" => "775" "link" => array:1 [ …1] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-Parkinsonism" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awh488" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2005" "volumen" => "128" "paginaInicial" => "1247" "paginaFinal" => "1258" "link" => array:1 [ …1] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2004" "volumen" => "63" "paginaInicial" => "1376" "paginaFinal" => "1384" "link" => array:1 [ …1] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-008-0397-8" "Revista" => array:7 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2008" "volumen" => "116" "paginaInicial" => "159" "paginaFinal" => "167" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extending the clinicopathological spectrum of neurofilament inclusion disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-004-0974-4" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2005" "volumen" => "109" "paginaInicial" => "427" "paginaFinal" => "432" "link" => array:1 [ …1] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneurol.2007.37" "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "2008" "volumen" => "65" "paginaInicial" => "272" "paginaFinal" => "275" "link" => array:1 [ …1] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "FUS pathology in basophilic inclusion body disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-009-0598-9" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2009" "volumen" => "118" "paginaInicial" => "617" "paginaFinal" => "627" "link" => array:1 [ …1] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A new subtype of frontotemporal lobar degeneration with FUS pathology" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awp214" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2009" "volumen" => "132" "paginaInicial" => "2922" "paginaFinal" => "2931" "link" => array:1 [ …1] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-009-0581-5" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2009" "volumen" => "118" "paginaInicial" => "605" "paginaFinal" => "616" "link" => array:1 [ …1] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "FUS pathology defines the majority of tau and TDP-43-negative frontotemporal lobar degeneration" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-010-0698-6" "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "2010" "volumen" => "120" "paginaInicial" => "33" "paginaFinal" => "41" "link" => array:1 [ …1] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between frontotemporal dementia, corticobasal degeneration, progressive supranuclear palsy and amyotrophic lateral sclerosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/WAD.0b013e31815bf454" "Revista" => array:6 [ "tituloSerie" => "Alzheimer Dis Assoc Disord" "fecha" => "2007" "volumen" => "21" "paginaInicial" => "S31" "paginaFinal" => "S38" "link" => array:1 [ …1] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The diagnostic and evolution of frontotemporal dementia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/WAD.0b013e31806547eb" "Revista" => array:6 [ "tituloSerie" => "Alzheimer Dis Assoc Disord" "fecha" => "2007" "volumen" => "21" "paginaInicial" => "155" "paginaFinal" => "163" "link" => array:1 [ …1] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/31508" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "1998" "volumen" => "393" "paginaInicial" => "702" "paginaFinal" => "705" "link" => array:1 [ …1] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hereditary frontotemporal dementia caused by Tau gene mutations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1750-3639.2007.00052.x" "Revista" => array:7 [ "tituloSerie" => "Brain Pathol" "fecha" => "2007" "volumen" => "17" "paginaInicial" => "63" "paginaFinal" => "73" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0205" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal dementia and Parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17t)" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "Neurodegeneration: the molecular pathology of dementia and movement disorders" "paginaInicial" => "86" "paginaFinal" => "102" "serieFecha" => "2003" ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0210" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuroimage.2009.12.088" "Revista" => array:6 [ "tituloSerie" => "Neuroimage" "fecha" => "2010" "volumen" => "53" "paginaInicial" => "1070" "paginaFinal" => "1076" "link" => array:1 [ …1] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0215" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000343851.46573.67" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2009" "volumen" => "72" "paginaInicial" => "813" "paginaFinal" => "820" "link" => array:1 [ …1] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0220" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2353/ajpath.2007.070182" "Revista" => array:6 [ "tituloSerie" => "Am J Pathol" "fecha" => "2007" "volumen" => "171" "paginaInicial" => "227" "paginaFinal" => "240" "link" => array:1 [ …1] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0225" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/nen.0b013e31803020cf" "Revista" => array:6 [ "tituloSerie" => "J Neuropathol Exp Neurol" "fecha" => "2007" "volumen" => "66" "paginaInicial" => "142" "paginaFinal" => "151" "link" => array:1 [ …1] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0230" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awl271" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2006" "volumen" => "129" "paginaInicial" => "3081" "paginaFinal" => "3090" "link" => array:1 [ …1] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0235" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3233/JAD-2011-101704" "Revista" => array:6 [ "tituloSerie" => "J Alzheimers Dis" "fecha" => "2011" "volumen" => "24" "paginaInicial" => "253" "paginaFinal" => "259" "link" => array:1 [ …1] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0240" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prominent phenotypic variability associated with mutations in progranulin" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neurobiolaging.2007.08.022" "Revista" => array:6 [ "tituloSerie" => "Neurobiol Aging" "fecha" => "2009" "volumen" => "30" "paginaInicial" => "739" "paginaFinal" => "751" "link" => array:1 [ …1] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0245" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awl276" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2006" "volumen" => "129" "paginaInicial" => "3115" "paginaFinal" => "3123" "link" => array:1 [ …1] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0250" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Corticobasal syndrome associated with the A9D progranulin mutation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/nen.0b013e3181567873" "Revista" => array:6 [ "tituloSerie" => "J Neuropathol Exp Neurol" "fecha" => "2007" "volumen" => "66" "paginaInicial" => "892" "paginaFinal" => "900" "link" => array:1 [ …1] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0255" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneur.64.1.43" "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "2007" "volumen" => "64" "paginaInicial" => "43" "paginaFinal" => "47" "link" => array:1 [ …1] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0260" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awl267" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2006" "volumen" => "129" "paginaInicial" => "3091" "paginaFinal" => "3102" "link" => array:1 [ …1] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0265" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/hmg/ddl241" "Revista" => array:6 [ "tituloSerie" => "Hum Mol Genet" "fecha" => "2006" "volumen" => "15" "paginaInicial" => "2988" "paginaFinal" => "3001" "link" => array:1 [ …1] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0270" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awn352" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2009" "volumen" => "132" "paginaInicial" => "583" "paginaFinal" => "591" "link" => array:1 [ …1] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0275" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000325058.10218.fc" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2008" "volumen" => "71" "paginaInicial" => "1235" "paginaFinal" => "1239" "link" => array:1 [ …1] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0280" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cerebrospinal fluid biomarkers in Progranulin mutations carriers" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3233/JAD-2011-111046" "Revista" => array:6 [ "tituloSerie" => "J Alzheimers Dis" "fecha" => "2011" "volumen" => "27" "paginaInicial" => "781" "paginaFinal" => "790" "link" => array:1 [ …1] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0285" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuron.2011.09.011" "Revista" => array:6 [ "tituloSerie" => "Neuron" "fecha" => "2011" "volumen" => "72" "paginaInicial" => "245" "paginaFinal" => "256" "link" => array:1 [ …1] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0290" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuron.2011.09.010" "Revista" => array:6 [ "tituloSerie" => "Neuron" "fecha" => "2011" "volumen" => "72" "paginaInicial" => "257" "paginaFinal" => "268" "link" => array:1 [ …1] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0295" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ng1332" "Revista" => array:6 [ …6] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0300" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP mutations" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/nen.0b013e31803020b9" "Revista" => array:6 [ …6] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0305" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chromosome 3 linked frontotemporal dementia (FTD-3)" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0310" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/hmg/ddm309" "Revista" => array:6 [ …6] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0315" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000231510.89311.8b" "Revista" => array:6 [ …6] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0320" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ng.132" "Revista" => array:6 [ …6] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0325" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1166066" "Revista" => array:6 [ …6] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0330" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1154584" "Revista" => array:6 [ …6] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0335" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1165942" "Revista" => array:6 [ …6] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0340" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuroimage.2008.05.012" "Revista" => array:6 [ …6] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0345" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000324924.91351.7d" "Revista" => array:6 [ …6] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0350" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/jnnp.2010.212225" "Revista" => array:6 [ …6] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib0355" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Towards a nosology for frontotemporal lobar degenerations – a meta-analysis involving 267 subjects" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuroimage.2007.03.024" "Revista" => array:7 [ …7] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib0360" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neural networks in frontotemporal dementia –a meta-analysis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neurobiolaging.2006.10.023" "Revista" => array:6 [ …6] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib0365" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cortical morphometric subclassification of frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3174/ajnr.A1545" "Revista" => array:7 [ …7] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib0370" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneur.63.10.1434" "Revista" => array:6 [ …6] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib0375" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eating and hypothalamus changes in behavioral-variant frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.22244" "Revista" => array:7 [ …7] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib0380" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patterns of white matter atrophy in frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneur.64.11.1619" "Revista" => array:6 [ …6] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib0385" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneurol.2007.38" "Revista" => array:6 [ …6] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib0390" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal dementia as a neural system disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neurobiolaging.2004.02.019" "Revista" => array:6 [ …6] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib0395" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development of an MRI rating scale for multiple brain regions: comparison with volumetrics and with voxel-based morphometry" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00234-009-0521-z" "Revista" => array:6 [ …6] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib0400" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rates of global and regional cerebral atrophy in AD and frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ …7] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib0405" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Staging disease severity in pathologically confirmed cases of frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib0410" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-004-0917-0" "Revista" => array:6 [ …6] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib0415" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Distribution of brain atrophy in behavioral variant frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jns.2005.02.003" "Revista" => array:6 [ …6] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib0420" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal dementia progresses to death faster than Alzheimer disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000173837.82820.9f" "Revista" => array:6 [ …6] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib0425" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal dementia: therapeutic interventions" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000197896" "Revista" => array:6 [ …6] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib0430" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000100973" "Revista" => array:6 [ …6] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib0435" "etiqueta" => "87" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000209507" "Revista" => array:6 [ …6] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib0440" "etiqueta" => "88" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Selective functional, regional, and neuronal vulnerability in frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/WCO.0b013e3283168e2d" "Revista" => array:6 [ …6] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib0445" "etiqueta" => "89" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neurodegenerative diseases target large-scale human brain networks" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuron.2009.03.024" "Revista" => array:6 [ …6] ] ] ] ] ] 89 => array:3 [ "identificador" => "bib0450" "etiqueta" => "90" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awq075" "Revista" => array:7 [ …7] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib0455" "etiqueta" => "91" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/jnnp.2006.114231" "Revista" => array:6 [ …6] ] ] ] ] ] 91 => array:3 [ "identificador" => "bib0460" "etiqueta" => "92" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0b013e3181a55fa2" "Revista" => array:6 [ …6] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib0465" "etiqueta" => "93" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awp232" "Revista" => array:6 [ …6] ] ] ] ] ] 93 => array:3 [ "identificador" => "bib0470" "etiqueta" => "94" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awr198" "Revista" => array:6 [ …6] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib0475" "etiqueta" => "95" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1533317507308779" "Revista" => array:6 [ …6] ] ] ] ] ] 95 => array:3 [ "identificador" => "bib0480" "etiqueta" => "96" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awm016" "Revista" => array:7 [ …7] ] ] ] ] ] 96 => array:3 [ "identificador" => "bib0485" "etiqueta" => "97" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awp071" "Revista" => array:6 [ …6] ] ] ] ] ] 97 => array:3 [ "identificador" => "bib0490" "etiqueta" => "98" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000238163.71349.78" "Revista" => array:6 [ …6] ] ] ] ] ] 98 => array:3 [ "identificador" => "bib0495" "etiqueta" => "99" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Distinct cerebral perfusion patterns in FTLD and AD" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0b013e3181f11e35" "Revista" => array:6 [ …6] ] ] ] ] ] 99 => array:3 [ "identificador" => "bib0500" "etiqueta" => "100" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0018111" "Revista" => array:5 [ …5] ] ] ] ] ] 100 => array:3 [ "identificador" => "bib0505" "etiqueta" => "101" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0b013e3181c0d427" "Revista" => array:7 [ …7] ] ] ] ] ] 101 => array:3 [ "identificador" => "bib0510" "etiqueta" => "102" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3233/JAD-2010-1401" "Revista" => array:6 [ …6] ] ] ] ] ] 102 => array:3 [ "identificador" => "bib0515" "etiqueta" => "103" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/jnnp.2010.209916" "Revista" => array:7 [ …7] ] ] ] ] ] 103 => array:3 [ "identificador" => "bib0520" "etiqueta" => "104" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0b013e3181ed9c52" "Revista" => array:6 [ …6] ] ] ] ] ] 104 => array:3 [ "identificador" => "bib0525" "etiqueta" => "105" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Delusions in frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00415-009-0128-7" "Revista" => array:7 [ …7] ] ] ] ] ] 105 => array:3 [ "identificador" => "bib0530" "etiqueta" => "106" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neurobiolaging.2008.11.009" "Revista" => array:6 [ …6] ] ] ] ] ] 106 => array:3 [ "identificador" => "bib0535" "etiqueta" => "107" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frontotemporal dementia mimicking dementia with Lewy bodies" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/WNN.0b013e3181864a09" "Revista" => array:6 [ …6] ] ] ] ] ] 107 => array:3 [ "identificador" => "bib0540" "etiqueta" => "108" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 108 => array:3 [ "identificador" => "bib0545" "etiqueta" => "109" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00259-008-0871-5" "Revista" => array:7 [ …7] ] ] ] ] ] 109 => array:3 [ "identificador" => "bib0550" "etiqueta" => "110" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1474-4422(10)70299-4" "Revista" => array:6 [ …6] ] ] ] ] ] 110 => array:3 [ "identificador" => "bib0555" "etiqueta" => "111" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Imaging beta-amyloid burden in aging and dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000261919.22630.ea" "Revista" => array:7 [ …7] ] ] ] ] ] 111 => array:3 [ "identificador" => "bib0560" "etiqueta" => "112" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "In vivo amyloid imaging with PET in frontotemporal dementia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00259-007-0523-1" "Revista" => array:6 [ …6] ] ] ] ] ] 112 => array:3 [ "identificador" => "bib0565" "etiqueta" => "113" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.20009" "Revista" => array:6 [ …6] ] ] ] ] ] 113 => array:3 [ "identificador" => "bib0570" "etiqueta" => "114" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000259035.98480.ed" "Revista" => array:6 [ …6] ] ] ] ] ] 114 => array:3 [ "identificador" => "bib0575" "etiqueta" => "115" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CSF markers for incipient Alzheimer's disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 115 => array:3 [ "identificador" => "bib0580" "etiqueta" => "116" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.289.16.2094" "Revista" => array:6 [ …6] ] ] ] ] ] 116 => array:3 [ "identificador" => "bib0585" "etiqueta" => "117" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CSF biomarkers in frontotemporal lobar degeneration with known pathology" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000311445.21321.fc" "Revista" => array:6 [ …6] ] ] ] ] ] 117 => array:3 [ "identificador" => "bib0590" "etiqueta" => "118" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneur.65.11.1481" "Revista" => array:6 [ …6] ] ] ] ] ] 118 => array:3 [ "identificador" => "bib0595" "etiqueta" => "119" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum biomarker for progranulin-associated frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.21621" "Revista" => array:7 [ …7] ] ] ] ] ] 119 => array:3 [ "identificador" => "bib0600" "etiqueta" => "120" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low serum progranulin predicts the presence of mutations: a prospective study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3233/JAD-2010-101032" "Revista" => array:6 [ …6] ] ] ] ] ] 120 => array:3 [ "identificador" => "bib0605" "etiqueta" => "121" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-009-0594-0" "Revista" => array:6 [ …6] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735808/0000003000000001/v2_201706020304/S2173580814001540/v2_201706020304/en/main.assets" "Apartado" => array:4 [ "identificador" => "9423" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735808/0000003000000001/v2_201706020304/S2173580814001540/v2_201706020304/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001540?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 0 | 4 |
2024 October | 27 | 10 | 37 |
2024 September | 69 | 13 | 82 |
2024 August | 50 | 9 | 59 |
2024 July | 31 | 4 | 35 |
2024 June | 26 | 9 | 35 |
2024 May | 33 | 5 | 38 |
2024 April | 62 | 8 | 70 |
2024 March | 60 | 1 | 61 |
2024 February | 39 | 9 | 48 |
2024 January | 31 | 10 | 41 |
2023 December | 39 | 10 | 49 |
2023 November | 28 | 6 | 34 |
2023 October | 46 | 12 | 58 |
2023 September | 29 | 6 | 35 |
2023 August | 31 | 6 | 37 |
2023 July | 17 | 12 | 29 |
2023 June | 31 | 7 | 38 |
2023 May | 81 | 8 | 89 |
2023 April | 75 | 6 | 81 |
2023 March | 66 | 4 | 70 |
2023 February | 30 | 7 | 37 |
2023 January | 30 | 16 | 46 |
2022 December | 35 | 9 | 44 |
2022 November | 64 | 20 | 84 |
2022 October | 58 | 24 | 82 |
2022 September | 68 | 10 | 78 |
2022 August | 38 | 18 | 56 |
2022 July | 28 | 15 | 43 |
2022 June | 33 | 17 | 50 |
2022 May | 23 | 19 | 42 |
2022 April | 57 | 22 | 79 |
2022 March | 69 | 15 | 84 |
2022 February | 51 | 10 | 61 |
2022 January | 95 | 13 | 108 |
2021 December | 59 | 19 | 78 |
2021 November | 48 | 17 | 65 |
2021 October | 36 | 16 | 52 |
2021 September | 36 | 15 | 51 |
2021 August | 29 | 18 | 47 |
2021 July | 13 | 19 | 32 |
2021 June | 22 | 11 | 33 |
2021 May | 35 | 24 | 59 |
2021 April | 70 | 34 | 104 |
2021 March | 46 | 15 | 61 |
2021 February | 33 | 14 | 47 |
2021 January | 48 | 19 | 67 |
2020 December | 49 | 17 | 66 |
2020 November | 46 | 23 | 69 |
2020 October | 47 | 14 | 61 |
2020 September | 41 | 26 | 67 |
2020 August | 44 | 13 | 57 |
2020 July | 31 | 23 | 54 |
2020 June | 25 | 23 | 48 |
2020 May | 37 | 22 | 59 |
2020 April | 35 | 18 | 53 |
2020 March | 32 | 7 | 39 |
2020 February | 45 | 15 | 60 |
2020 January | 35 | 8 | 43 |
2019 December | 35 | 24 | 59 |
2019 November | 20 | 8 | 28 |
2019 October | 24 | 12 | 36 |
2019 September | 27 | 9 | 36 |
2019 August | 19 | 6 | 25 |
2019 July | 39 | 19 | 58 |
2019 June | 91 | 15 | 106 |
2019 May | 145 | 22 | 167 |
2019 April | 73 | 80 | 153 |
2019 March | 49 | 12 | 61 |
2019 February | 81 | 15 | 96 |
2019 January | 83 | 13 | 96 |
2018 December | 79 | 17 | 96 |
2018 November | 91 | 6 | 97 |
2018 October | 103 | 16 | 119 |
2018 September | 202 | 17 | 219 |
2018 August | 67 | 6 | 73 |
2018 July | 11 | 4 | 15 |
2018 June | 25 | 11 | 36 |
2018 May | 35 | 8 | 43 |
2018 April | 36 | 12 | 48 |
2018 March | 22 | 3 | 25 |
2018 February | 11 | 4 | 15 |
2018 January | 8 | 1 | 9 |
2017 December | 22 | 3 | 25 |
2017 November | 30 | 3 | 33 |
2017 October | 23 | 4 | 27 |
2017 September | 34 | 4 | 38 |
2017 August | 30 | 7 | 37 |
2017 July | 25 | 1 | 26 |
2017 June | 43 | 8 | 51 |
2017 May | 50 | 5 | 55 |
2017 April | 40 | 3 | 43 |
2017 March | 36 | 19 | 55 |
2017 February | 96 | 2 | 98 |
2017 January | 29 | 2 | 31 |
2016 December | 39 | 10 | 49 |
2016 November | 65 | 10 | 75 |
2016 October | 94 | 10 | 104 |
2016 September | 155 | 7 | 162 |
2016 August | 90 | 3 | 93 |
2016 July | 67 | 3 | 70 |
2016 June | 51 | 16 | 67 |
2016 May | 59 | 13 | 72 |
2016 April | 59 | 20 | 79 |
2016 March | 63 | 27 | 90 |
2016 February | 65 | 13 | 78 |
2016 January | 40 | 14 | 54 |
2015 December | 45 | 13 | 58 |
2015 November | 48 | 11 | 59 |
2015 October | 56 | 18 | 74 |
2015 September | 52 | 14 | 66 |
2015 August | 75 | 7 | 82 |
2015 July | 63 | 8 | 71 |
2015 June | 35 | 11 | 46 |
2015 May | 31 | 17 | 48 |
2015 April | 53 | 18 | 71 |
2015 March | 62 | 17 | 79 |
2015 February | 112 | 35 | 147 |